Literature DB >> 25031753

Cytoplasmic HSP90α expression is associated with perineural invasion in pancreatic cancer.

Hua Jiang1, Bensong Duan2, Chengzhi He3, Shasha Geng1, Xiaoying Shen4, Hongmei Zhu4, Haihui Sheng5, Changqing Yang3, Hengjun Gao6.   

Abstract

Pancreatic cancer (PC) is an aggressive and devastating disease with a dismal prognosis. The study aimed to investigate the role of HSP90α and PDIA3 in patients with PC. Immunohistochemistry was performed on tissue microarrays containing 186 pairs of PC and normal pancreatic tissues to assess the expression levels of HSP90α and PDIA3. The expression levels of cytoplasmic HSP90α (P = 0.032) and PDIA3 (P = 0.043) in PCs were significantly higher than those in normal pancreas tissues, but nuclear HSP90α showed lower expression in PC tissues (P = 0.002). In addition, cytoplasmic expression of HSP90α and PDIA3 was significantly associated with perineural invasion (PNI) (P = 0.004) and sex (P = 0.014), respectively. These results indicate that cytoplasmic HSP90α may serve as a biomarker for PNI in PCs.

Entities:  

Keywords:  HSP90α; PDIA3; Pancreatic cancer; perineural invasion

Mesh:

Substances:

Year:  2014        PMID: 25031753      PMCID: PMC4097286     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  33 in total

Review 1.  Regulatory role of the 90-kDa-heat-shock protein (Hsp90) and associated factors on gene expression.

Authors:  Alejandra G Erlejman; Mariana Lagadari; Judith Toneatto; Graciela Piwien-Pilipuk; Mario D Galigniana
Journal:  Biochim Biophys Acta       Date:  2014-01-03

2.  Secreted heat shock protein 90α (HSP90α) induces nuclear factor-κB-mediated TCF12 protein expression to down-regulate E-cadherin and to enhance colorectal cancer cell migration and invasion.

Authors:  Wei-Shone Chen; Chia-Chi Chen; Li-Li Chen; Chun-Chung Lee; Tze-Sing Huang
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

3.  Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Xuelin Zhang; Chengzhi He; Chunya He; Baofu Chen; Yanxia Liu; Min Kong; Chunguo Wang; Lizhong Lin; Yan Dong; Haihui Sheng
Journal:  Pathol Res Pract       Date:  2013-06-28       Impact factor: 3.250

4.  Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer.

Authors:  Charles M Leys; Sachiyo Nomura; Bonnie J LaFleur; Soldano Ferrone; Michio Kaminishi; Elizabeth Montgomery; James R Goldenring
Journal:  Surgery       Date:  2006-08-14       Impact factor: 3.982

5.  Targeting PI3K/Akt/HSP90 signaling sensitizes gastric cancer cells to deoxycholate-induced apoptosis.

Authors:  Maria J Redlak; Thomas A Miller
Journal:  Dig Dis Sci       Date:  2010-06-29       Impact factor: 3.199

6.  Expression of c-Myc and Fas correlates with perineural invasion of pancreatic cancer.

Authors:  Chengzhi He; Hua Jiang; Shasha Geng; Haihui Sheng; Xiaoying Shen; Xiaoyan Zhang; Shizhang Zhu; Ximei Chen; Changqing Yang; HengJun Gao
Journal:  Int J Clin Exp Pathol       Date:  2012-04-16

7.  Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.

Authors:  Antoine Ménoret; David A Drew; Shingo Miyamoto; Masako Nakanishi; Anthony T Vella; Daniel W Rosenberg
Journal:  Mol Carcinog       Date:  2012-12-19       Impact factor: 4.784

Review 8.  Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment.

Authors:  Andrei Laszlo; Dinesh Thotala; Dennis E Hallahan
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

9.  UNC51-like kinase 1 as a potential prognostic biomarker for hepatocellular carcinoma.

Authors:  Hongtao Xu; Hong Yu; Xiaoyan Zhang; Xiaoying Shen; Kehao Zhang; Haihui Sheng; Shengbin Dai; Hengjun Gao
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

10.  A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer.

Authors:  Shanu Modi; Cristina Saura; Charles Henderson; Nancy U Lin; Reshma Mahtani; Jill Goddard; Eduardo Rodenas; Clifford Hudis; Joyce O'Shaughnessy; Jose Baselga
Journal:  Breast Cancer Res Treat       Date:  2013-04-12       Impact factor: 4.872

View more
  6 in total

1.  Mining Exosomal Genes for Pancreatic Cancer Targets.

Authors:  Amy Makler; Ramaswamy Narayanan
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

2.  Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription.

Authors:  Tao Pan; Zhenjia Yu; Zhijian Jin; Xiongyan Wu; Airong Wu; Junyi Hou; Xinyu Chang; Zhiyuan Fan; Jianfang Li; Beiqin Yu; Fangyuan Li; Chao Yan; Zhongyin Yang; Zhenggang Zhu; Bingya Liu; Liping Su
Journal:  Mol Ther Nucleic Acids       Date:  2021-02-10       Impact factor: 8.886

3.  Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion.

Authors:  Takanobu Takata; Tadashi Ueda; Akiko Sakasai-Sakai; Masayoshi Takeuchi
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

4.  Diagnostic value of HSP90α and related markers in lung cancer.

Authors:  Zhimin Yuan; Longhao Wang; Songlin Hong; Changbei Shi; Bin Yuan
Journal:  J Clin Lab Anal       Date:  2022-05-06       Impact factor: 3.124

5.  Analysis of the prognostic, diagnostic and immunological role of HSP90α in malignant tumors.

Authors:  Zhimin Yuan; Longhao Wang; Cheng Chen
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

6.  A secretome profile indicative of oleate-induced proliferation of HepG2 hepatocellular carcinoma cells.

Authors:  Soyeon Park; Ji-Hwan Park; Hee-Jung Jung; Jin-Hyeok Jang; Sanghyun Ahn; Younah Kim; Pann-Ghill Suh; Sehyun Chae; Jong Hyuk Yoon; Sung Ho Ryu; Daehee Hwang
Journal:  Exp Mol Med       Date:  2018-08-03       Impact factor: 8.718

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.